Menachem Ash Voluntarily Resigns as President and General Counsel of Rafael Holdings, Inc
September 24, 2021 at 08:08 am
Share
On September 20, 2021, Menachem Ash voluntarily resigned as President and General Counsel of Rafael Holdings, Inc. The Company and Mr. Ash have agreed that Mr. Ash will assist in the transition of his duties to Ashok Marin, the Company’s Chief Legal Officer, and provide transition support on matters that relate to events during Mr. Ash’s tenure with the Company. In connection with those services, the anticipated January 2022 vesting of Mr. Ash’s prior grant of restricted stock in the Company will take place.
Rafael Holdings, Inc. is a holding company with interests in clinical and early-stage pharmaceutical companies. The Company's segments include healthcare and real estate. The Company's investments include Cornerstone Pharmaceuticals, Inc., which is a cancer metabolism-based therapeutics company; LipoMedix Pharmaceuticals Ltd., which is a clinical-stage pharmaceutical company; Barer Institute Inc., which is a preclinical cancer metabolism research operation; Cyclo Therapeutics Inc., which is a clinical-stage biotechnology company dedicated to developing medicines for patients and families living with diseases through its therapeutic asset like Trappsol and Cyclo; Day Three Labs, Inc., which offers pharmaceutical-grade technology like Unlokt, and Rafael Medical Devices, LLC, which is an orthopedic-focused medical device company developing instruments to advance minimally invasive surgeries. Its real estate segment comprises of a portion of a commercial building in Israel.